SynthesisAnnals of hematology2021

Dawn of a new era of antibody-drug conjugates and bispecific T-cell engagers for treatment of multiple myeloma: a systematic review of literature.

Zoia Ehsan Khattak et al.PubMed ↗Publisher ↗

No numbers read from the abstract.